Institute of Sports Medicine, Copenhagen Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2018
NCT03401177
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Institute of Sports Medicine, Copenhagen

Active Ingredients

Drugs in Other Trials (1)

naproxen (naprosyn) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1